Abtrace

accuRx, Series B round, vaccine booking system, Abtrace
By  Sara Mageit 02:58 am September 15, 2021
London-based healthcare platform accuRx today announced a £27.5 million Series B funding boost. The round was led by Lakestar with participation from British Patient Capital, Latitude VS, Atomico, Trusted Insight and Encore Capital.  WHAT IT DOES Founded in 2016, accuRx’s mission is to bring patients and their healthcare teams together. Its platform is used by 98% of GP practices in England and...
The company uses machine learning to detect, monitor and treat chronic and long-term health conditions.
By  Sara Mageit 07:08 am August 26, 2021
London-based healthtech company Abtrace has raised £2.1 million of seed funding in a round led by Faber and joined by Ganexa Capital. The Abtrace technology aims to enable the management of long-term health conditions to move from a reactive, to a proactive process informed by data.  WHY IT MATTERS Abtrace has built an AI tool which can plug-into the Electronic Health Record (EHR) database and...